New research published in BMJ Paediatrics Open is prompting calls for further exploration of the potential therapeutic benefits of whole-plant medicinal cannabis products in treating epileptic children.
Story continues below
This advertisement has not loaded yet, but your article continues below.
As the authors of the study note, anecdotal evidence on the value of medicinal cannabis for treating childhood epilepsies has been accumulating since the 1800s, but doctors in the U.K. have been hesitant to prescribe medical cannabis products, citing a lack of clinical trial data.
This latest research focused on 10 children, ranging from 1- to 13-years-old, whose severe epilepsy hadn’t responded to both conventional treatments and cannabidiol (CBD) oil.
Story continues below
Read full article on The Growth Op
